ECR 2010 / C-3429
Whole body diffusion-weighted and ADC mapping , and STIR MRI versus PET/CT in relapsing lymphoma
Keywords:
Molecular imaging
Authors:
M. H. A. Abdel Salam, A. Y. Attallah ; Cairo/EG
DOI:
10.1594/ecr2010/C-3429
References
References:
- Schmidt G, Reiser M, Baur-Melnyk A. Whole-body MRI for the staging and follow-up of patients with metastasis. EJR. 2009; 70:393-400.
- Walker R, Kessar P, Blanchard R, et al.. Turbo STIR magnetic resonance imaging as awhole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging. 2000; 11:343-350.
- Lauenstein TC, Goehde SC, Herborn CU, et al. Whole-body MR imaging:evaluation of patients for metastases. Radiology. 2004; 233:139-148.
- Schlemmer HP, Schafer J, Pfannenberg C, et al. Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system:initial experiences. Invest Radiol. 2005; 40:64-71.
- Eustace S, Tello R, Decarvalho V et al. A comparison of whole-body turbo short tau inversion recovery MR imaging and plan technetium 99m methylene diphosphonate scintigraphy in the evaluation of patients with suspected skeletal metastases. AJR. 1997; 169:1655-1661.
- Montraves F, McNamara D, Landaman-Parker J, et al. FDG in childhood lymphoma: clinical utility and impact on management. Eur J Nucl Med Mol Imaging. 2002; 29:1155-1165.
- Burton C, Ell P, Linch D. The role of Pet imaging in lymphoma. Br J Hematol. 2004; 126:772-784.
- Kazama T, Faria SC, Varavithya V, et al. FDG-PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls. Radiographics. 2005; 25:191-207.
- Divgi C. Imaging, staging, and evaluation of lymphoma using nuclear medicine. Semin Oncol. 2005; 32:S11-S18.
- Samelka RC, Worawattanakul S, Kelekis NL, et al. Liver lesion detection, characterization, effect on patient management: comparison of single phase spiral-CT and current MR trchnique. J Reson Imaging. 1997; 7:1040-1047.
- Stecco A, Romano G, Negru M, et al. Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study. Radiol med. 2009; 114:1-17.
- Shields AF, Porter BA, Churchley S, et al. The detection of bone marrow involvement by lymphoma using magnetic resonance imaging. J Clin Oncol. 1987; 5:223-230.
- Linden A, Zankovich R, Theissen P et al. Malignant lymphoma: bone marrow imaging versus biopsy. Radiology. 1989; 173; 335-339.
- Dohner H, Guckel F, Knauf W, et al. Magnetic resonance imaging of bone marrow in lymphoproliferative disorders: correlation with bone marrow biopsy. Br J hematol. 1989; 73:12-17.
- Hoane BR, Shields AF, Porter BA, et al. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging. Blood. 2991; 78:728-738.
- Tardivon AA, Munck JN, Shapero LG, et al. Can clinical data help to sreen patients with lymphoma for MR imagingof bone marrow. Ann Oncol. 1995; 6:795-800.
- Varan A, Cila A, Buykpamukcu M. Prognostic importance of magnetic resonance imaging in bone marrow involvement in hodghin’s disease. Med Pediatr Oncol. 1999; 32:267-271.
- Kellenberger CJ, Miller SF, Khan M, et al. Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children. Eur Radiol. 2004; 14:1829-1841.
- Walker RE, Eustace SJ. Whole-body magnetic resonance imaging: techniques, clinical indications, and future applications. Semin Musculoskelet Radiol. 2001; 5:5-20.
- Kavanagh E, Smith C, Eustace S. Whole-body turbo STIR MR imaging;controversies and avenues for development. Eur Radiol. 2003; 21:2196-2205.
- Lichy MP, Aschoff P, Plathow C, et al. Tumor detection by diffusion-weighted MRI and ADC-maping_initial clinical experiences in comparison to PET/CT. Invest Radiol. 2007; 42:605-613.